Klein Thomas, Magerl Walter, Nickel Ursula, Hopf Hanns-Christian, Sandkühler Jürgen, Treede Rolf-Detlef
Institute of Physiology and Pathophysiology, Johannes Gutenberg-University, Saarstrasse 21, D-55099 Mainz, Germany.
Neuropharmacology. 2007 Feb;52(2):655-61. doi: 10.1016/j.neuropharm.2006.09.008. Epub 2006 Nov 3.
We recently reported perceptual correlates of long-term potentiation (LTP) of synaptic strength within the nociceptive system demonstrating the functional relevance of LTP for human pain sensation. LTP is generally classified as NMDA-receptor dependent or independent. Here we show that low doses of the NMDA-receptor antagonist ketamine (0.25 mg/kg) prevented the long-term increase in perceived pain to electrical test stimuli, which was induced by high-frequency electrical stimulation (HFS) of nociceptive afferents. Whereas in a control experiment HFS led to a stable increase in perceived pain by 51% for the entire observation period of 1h HFS given 4 min after i.v. ketamine was ineffective. In contrast, HFS induced a two-fold increase of pinprick-evoked pain surrounding the HFS site (secondary neurogenic hyperalgesia) in both experiments. Pain evoked by light tactile stimuli (allodynia) was also unaffected by ketamine. These data support the concept that homotopic hyperalgesia to electrical stimulation of the conditioned pathway is a perceptual correlate of NMDA-receptor sensitive homosynaptic LTP in the nociceptive system, e.g. in the spinal cord. Although secondary neurogenic hyperalgesia and allodynia are induced by the same HFS protocol, they involve additional NMDA-receptor insensitive mechanisms of heterosynaptic facilitation.
我们最近报道了伤害性感受系统中突触强度的长期增强(LTP)的感知相关性,证明了LTP对人类疼痛感觉的功能相关性。LTP通常分为依赖NMDA受体或不依赖NMDA受体。在这里,我们表明低剂量的NMDA受体拮抗剂氯胺酮(0.25mg/kg)可防止对电测试刺激的疼痛感知长期增加,这种增加是由伤害性传入神经的高频电刺激(HFS)诱导的。而在对照实验中,静脉注射氯胺酮4分钟后给予1小时的HFS,在整个观察期内,HFS导致疼痛感知稳定增加51%,但氯胺酮无效。相比之下,在两个实验中,HFS均诱导HFS部位周围针刺诱发疼痛增加两倍(继发性神经源性痛觉过敏)。轻触觉刺激诱发的疼痛(痛觉过敏)也不受氯胺酮影响。这些数据支持这样的概念,即对条件通路电刺激的同位痛觉过敏是伤害性感受系统(如脊髓)中NMDA受体敏感的同突触LTP的一种感知相关性。尽管继发性神经源性痛觉过敏和痛觉过敏是由相同的HFS方案诱导的,但它们涉及异突触易化的额外NMDA受体不敏感机制。